{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:57:14Z","timestamp":1740149834042,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12328-017-0785-5","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T03:18:29Z","timestamp":1508383109000},"page":"564-569","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma"],"prefix":"10.1007","volume":"10","author":[{"given":"Minami","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-1557","authenticated-orcid":false,"given":"Takuto","family":"Hikichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaku","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hando","family":"Hakozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ejiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"785_CR1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3748\/wjg.v18.i8.736","volume":"18","author":"JE Ying","year":"2012","unstructured":"Ying JE, Zhu LM, Liu BX. Developments in metastatic pancreatic cancer: is gemcitabine still the standard? World J Gastroenterol. 2012;18:736\u201345.","journal-title":"World J Gastroenterol"},{"key":"785_CR2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.2016.45","volume":"114","author":"SM Stein","year":"2016","unstructured":"Stein SM, James ES, Deng Y, et al. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer. Br J Cancer. 2016;114:737\u201343.","journal-title":"Br J Cancer"},{"key":"785_CR3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1634\/theoncologist.2011-0231","volume":"16","author":"MA Lowery","year":"2011","unstructured":"Lowery MA, Klimstra DS, Shia J, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist. 2011;16:1714\u201320.","journal-title":"Oncologist"},{"key":"785_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jcp.30.2.103","volume":"30","author":"JN Webb","year":"1977","unstructured":"Webb JN. Acinar cell neoplasms of the exocrine pancreas. J Clin Pathol. 1977;30:103\u201312.","journal-title":"J Clin Pathol"},{"key":"785_CR5","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s11605-008-0705-6","volume":"12","author":"CM Schmidt","year":"2008","unstructured":"Schmidt CM, Matos JM, Bentrem DJ, et al. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg. 2008;12:2078\u201386.","journal-title":"J Gastrointest Surg"},{"key":"785_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/mpa.0b013e31804bfbd3","volume":"35","author":"H Kitagami","year":"2007","unstructured":"Kitagami H, Kondo S, Hirano S, et al. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas. 2007;35:42\u20136.","journal-title":"Pancreas"},{"key":"785_CR7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jjco\/hyp085","volume":"39","author":"Y Seki","year":"2009","unstructured":"Seki Y, Okusaka T, Ikeda M, et al. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent. Jpn J Clin Oncol. 2009;39:751\u20135.","journal-title":"Jpn J Clin Oncol"},{"key":"785_CR8","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1200\/JCO.2002.02.005","volume":"20","author":"KD Holen","year":"2002","unstructured":"Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol. 2002;20:4673\u20138.","journal-title":"J Clin Oncol"},{"key":"785_CR9","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/00006676-200307000-00019","volume":"27","author":"JL Lee","year":"2003","unstructured":"Lee JL, Kim TW, Chang HM, et al. Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases. Pancreas. 2003;27:e18\u201322.","journal-title":"Pancreas"},{"key":"785_CR10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4143\/crt.2016.371","volume":"49","author":"C Yoo","year":"2017","unstructured":"Yoo C, Kim BJ, Kim KP, et al. Efficacy of chemotherapy in patients with unresectable or metastatic pancreatic acinar cell carcinoma: potentially improved efficacy with oxaliplatin-containing regimen. Cancer Res Treat. 2017;49:759\u201365.","journal-title":"Cancer Res Treat."},{"key":"785_CR11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","volume":"160","author":"SC Abraham","year":"2002","unstructured":"Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/beta-catenin pathway. Am J Pathol. 2002;160:953\u201362.","journal-title":"Am J Pathol"},{"key":"785_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1159\/000355320","volume":"6","author":"S Pfrommer","year":"2013","unstructured":"Pfrommer S, Weber A, Dutkowski P, et al. Successful salvage chemotherapy with FOLFIRINOX for recurrent mixed acinar cell carcinoma and ductal adenocarcinoma of the pancreas in an adolescent patient. Case Rep Oncol. 2013;6:497\u2013503.","journal-title":"Case Rep Oncol"},{"key":"785_CR13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0033-1356439","volume":"52","author":"U Schempf","year":"2014","unstructured":"Schempf U, Sipos B, K\u00f6nig C, et al. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report. Z Gastroenterol. 2014;52:200\u20133.","journal-title":"Z Gastroenterol"},{"key":"785_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pan.2015.04.006","volume":"15","author":"HR Callata-Carhuapoma","year":"2015","unstructured":"Callata-Carhuapoma HR, Pato Cour E, Garcia-Paredes B, et al. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature. Pancreatology. 2015;15:440\u20134.","journal-title":"Pancreatology"},{"key":"785_CR15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3892\/mco.2017.1240","volume":"6","author":"T Yoshihiro","year":"2017","unstructured":"Yoshihiro T, Nio K, Tsuchihashi K, et al. Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: a case report. Mol Clin Oncol. 2017;6:866\u201370.","journal-title":"Mol Clin Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-017-0785-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-017-0785-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T12:07:27Z","timestamp":1511179647000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-017-0785-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["785"],"URL":"https:\/\/doi.org\/10.1007\/s12328-017-0785-5","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}